查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1757976

全球血管移植市場

Artificial Blood Vessels
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球血管移植市場規模將達到 3.795 億美元

全球血管移植市場規模預計在2024年為2.927億美元，到2030年將達到3.795億美元，在2024-2030年的分析期間內，複合年成長率為4.4%。氧環己酮聚合體是本報告分析的細分市場之一，預計其複合年成長率為5.4%，到分析期結束時規模將達到1.779億美元。彈性體聚合物細分市場在分析期間的複合年成長率預計為3.0%。

美國市場規模估計為 7,970 萬美元，中國市場預計複合年成長率為 8.2%

美國血管移植市場規模預計2024年達到7,970萬美元。作為世界第二大經濟體，中國預計在2030年達到7,910萬美元的市場規模，2024年至2030年的複合年成長率為8.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.8%和3.5%。在歐洲，預計德國的複合年成長率為2.6%。

全球血管假體市場－主要趨勢與促進因素摘要

生物工程血管移植：心血管外科的未來？

血管移植市場正蓬勃發展，主要原因是心血管和周邊動脈疾病對可靠血管移植的需求不斷成長。合成和生物工程血管正在血管外科手術中發揮變革性的作用，尤其適用於自體血管無法移植的患者。傳統上，血管移植主要使用發泡聚四氟乙烯 (ePTFE) 和聚酯纖維等材料，如今，人們開始轉向模擬自身血管結構和功能的組織工程血管移植 (TEVG)。這些新型血管移植已展現出卓越的生物相容性、較低的血栓形成風險和更高的通暢率。 3D 生物列印和支架製造技術的進步正在突破客製化的界限，使患者特異性的血管移植成為可能，從而改善手術效果。此外，幹細胞技術和再生醫學的創新使得能夠創建與宿主組織無縫整合並促進內皮化的移植血管成為可能。這對於需要隨兒童成長進行血管重組的兒科患者尤其有益。奈米技術與表面改質的結合，進一步增強了合成移植物的機械強度和抗發炎特性。此外，對去細胞天然血管的研究，為新的現成解決方案鋪平了道路，這些解決方案將天然組織的結構完整性與無菌移植物的安全性相結合。該領域處於生物技術、材料科學和臨床醫學的交叉點，標誌著心血管修復與重組未來邁出了重要的一步。

日益加重的疾病負擔和手術需求如何影響市場趨勢？

全球心血管疾病（CVD），尤其是動脈硬化、動脈瘤和周邊動脈疾病的負擔，是血管移植市場擴張的強大驅動力。世界人口老化，加上久坐不動的生活方式以及肥胖和糖尿病發病率的上升，導致血管併發症通常需要外科手術干預。在許多情況下，患者本身沒有適合移植的靜脈或動脈，這使得合成替代物不僅是一種選擇，更是一種必需品。冠狀動脈繞道手術手術（CABG）和末期腎衰竭患者的血液透析機通路是合成移植物最常被廣泛使用的應用領域。包括微創血管外科在內的新型外科技術正在推動對靈活、耐用且適應性強的合成移植物的需求。同時，已開發國家和新興國家的醫療保健系統都在擴大其執行複雜血管介入的能力，從而增加了手術量，進而增加了器械使用量。此外，無論是軍事還是民用領域，涉及大血管的創傷、先天性心臟疾病和腫瘤切除術也推動了其使用案例的增加。在中低收入國家，外科基礎設施的改善和政府對心臟照護的投入進一步推動了市場滲透。緊急手術對可靠血管導管的需求，加上全球對血管健康的日益關注，使得血管移植物成為現代外科手術方案的前沿。

監管和臨床挑戰是否正在改變創新格局？

儘管技術不斷進步，血管移植市場仍受複雜的法規環境和臨床挑戰的影響。由於心血管應用的高風險性，血管移植（尤其是組織工程和生物可吸收移植）的監管核准流程極為嚴格。其安全性、耐用性、生物相容性和長期療效必須透過臨床前和多期臨床試驗進行全面驗證。這通常會導致產品開發週期延長和成本增加，除非與成熟的醫療設備公司或學術機構合作，否則小型創新企業將難以進入市場。此外，移植排斥反應、感染風險、動脈瘤變性以及小直徑移植（尤其是 6 毫米或更小）的通暢性有限等問題仍然是臨床應用的重大障礙。這些挑戰促使人們進行大量研究，旨在開發將合成支架與生物成分結合的混合移植，以降低免疫抗原性並提高完整性。生物技術公司、大學和醫院之間的合作在尋求克服轉化差距和簡化臨床檢驗流程的相關人員中變得越來越普遍。此外，上市後監測和基於價值的醫療保健指標的實施，正迫使製造商投資於長期療效研究和真實世界證據。在全球範圍內，市場准入受到不同報銷政策的影響，尤其是在新興國家，高昂的移植成本可能會限制其應用。然而，政府支持的創新生態系統和私人對醫療技術研發投資的不斷增加，逐漸改變這些動態，推動推出更具臨床和商業性可行性的下一代血管移植物。

推動全球市場成長的主要因素有哪些？

血管移植市場的成長受到多種因素的驅動，這些因素深深植根於臨床需求、技術創新、不斷擴大的醫療基礎設施以及不斷變化的治療模式。其中最主要的是全球心血管和周邊血管手術數量的增加。這主要是由於生活方式驅動的慢性疾病和與老齡化相關的血管退化的盛行率不斷上升。生醫材料技術的進步，例如生物分解性聚合物和生物活性塗層的開發，使得能夠製造出抗感染、血栓症和抗機械疲勞的血管移植。 3D 列印（尤其是生物列印）的快速發展使得能夠生產根據個體解剖結構量身定做的移植，從而減少併發症並提高手術成功率。由於接受慢性腎臟替代治療的患者對血管通路解決方案的需求很高，透析基礎設施的擴展也是一個主要的成長動力。此外，越來越多的專業心血管中心（尤其是在新興市場），正在將人工移植納入其標準手術套件包中。消費者行為也發揮作用，越來越多的患者選擇微創手術，這些手術需要更早的手術介入和更高性能的移植材料。醫院、研究機構和外科中心等終端使用者越來越傾向於與醫療設備公司合作，共同開發下一代移植技術。此外，遠端醫療和遠端監控工具的興起改善了術後管理，帶來了更好的療效，並增強了人們對使用人工移植材料的信心。這些因素共同推動全球血管移植市場邁向持續技術創新、應用日益普及和擴張式成長的時期。

部分

聚合物（氧環己酮聚合體聚合物、彈性體聚合物、聚對苯二甲酸乙二醇酯聚合物、其他聚合物）、應用（主動脈疾病應用、周邊動脈疾病應用、血液透析機應用）

受訪企業範例（共34家）

  • Abbott Laboratories
  • ArtiCasc 3D
  • Artivion, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Getinge AB
  • Humacyte Inc.
  • Integra LifeSciences Holdings Corp.
  • Jiangsu Bioda Life Science Co., Ltd.
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Roumai Med
  • Smith & Nephew plc
  • Techshot Inc.
  • Terumo Corporation
  • WL Gore & Associates, Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP36197

Global Artificial Blood Vessels Market to Reach US$379.5 Million by 2030

The global market for Artificial Blood Vessels estimated at US$292.7 Million in the year 2024, is expected to reach US$379.5 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Polydioxanone Polymer, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$177.9 Million by the end of the analysis period. Growth in the Elastomer Polymer segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$79.7 Million While China is Forecast to Grow at 8.2% CAGR

The Artificial Blood Vessels market in the U.S. is estimated at US$79.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$79.1 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Artificial Blood Vessels Market - Key Trends & Drivers Summarized

Are Bioengineered Vascular Grafts the Future of Cardiovascular Surgery?

The artificial blood vessels market is gaining remarkable momentum, primarily driven by the need for reliable vascular grafts in cardiovascular and peripheral artery diseases. Synthetic and bioengineered blood vessels are playing a transformative role in vascular surgeries, particularly in patients where natural vessels are unsuitable for grafting. Traditionally dominated by materials like expanded polytetrafluoroethylene (ePTFE) and Dacron, the market is now witnessing a shift toward tissue-engineered vascular grafts (TEVGs) that mimic the structure and function of native blood vessels. These newer grafts offer better biocompatibility, reduced thrombogenicity, and higher patency rates. Advances in 3D bioprinting and scaffold fabrication are pushing the boundaries of customization, enabling patient-specific grafts that improve surgical outcomes. Moreover, innovations in stem cell technology and regenerative medicine have made it possible to create grafts that integrate seamlessly with the host tissue and promote endothelialization. This is particularly beneficial in pediatric patients requiring vascular reconstructions that grow along with the child. The integration of nanotechnology and surface modifications is further enhancing the mechanical strength and anti-inflammatory properties of synthetic grafts. Additionally, research into decellularized natural vessels is opening new avenues for off-the-shelf solutions that combine the structural integrity of native tissues with the safety of sterilized grafts. The field is at the convergence of biotechnology, materials science, and clinical medicine, signaling a major leap toward the future of cardiovascular repair and reconstruction.

How Are Rising Disease Burdens and Surgical Needs Influencing Market Trajectories?

The global burden of cardiovascular diseases (CVDs), especially atherosclerosis, aneurysms, and peripheral arterial disease, is a powerful driver behind the expanding artificial blood vessels market. An aging global population, combined with increasingly sedentary lifestyles and rising rates of obesity and diabetes, is contributing to a surge in vascular complications that often necessitate surgical intervention. In many cases, patients lack suitable autologous veins or arteries for grafting, making artificial alternatives not just optional but essential. Coronary artery bypass grafting (CABG) and hemodialysis access in patients with end-stage renal disease are among the most common applications where artificial grafts are extensively used. Emerging surgical techniques, including minimally invasive vascular surgeries, are increasing the demand for flexible, durable, and highly compatible synthetic grafts. Simultaneously, healthcare systems across both developed and emerging nations are expanding their capabilities to perform complex vascular interventions, thereby increasing procedural volumes and, by extension, device utilization. Furthermore, traumatic injuries, congenital heart defects, and tumor resections involving major vessels in both military and civilian populations are creating additional use cases for artificial blood vessels. In low- and middle-income countries, improving surgical infrastructure and government investment in cardiac care are further stimulating market penetration. The need for reliable vascular conduits in emergency surgeries, coupled with greater global awareness of vascular health, is placing artificial blood vessels at the forefront of modern surgical planning.

Are Regulatory and Clinical Challenges Reshaping the Innovation Landscape?

Despite substantial technological advancement, the artificial blood vessels market remains shaped by a complex regulatory environment and significant clinical challenges. Regulatory approval processes for vascular grafts, particularly tissue-engineered and bioresorbable ones, are extremely rigorous due to the high-risk nature of cardiovascular applications. Safety, durability, biocompatibility, and long-term efficacy must be extensively demonstrated through preclinical and multi-phase clinical trials. This often extends product development timelines and increases costs, limiting the entry of smaller innovators unless they partner with established medical device companies or academic institutions. Furthermore, issues like graft rejection, infection risk, aneurysmal degeneration, and limited patency in small-diameter grafts-especially those under 6mm-continue to pose significant clinical hurdles. These challenges have fueled a wave of research aimed at developing hybrid grafts that combine synthetic scaffolds with biological components to reduce immunogenicity and enhance integration. Collaborations between biotech firms, universities, and hospitals are becoming more common as stakeholders seek to overcome translational gaps and streamline clinical validation processes. Additionally, the implementation of post-market surveillance and value-based healthcare metrics is forcing manufacturers to invest in long-term outcome studies and real-world evidence. On a global scale, market access is influenced by variable reimbursement policies, particularly in emerging economies where high graft costs can limit adoption. However, government-supported innovation ecosystems and rising private investment in medtech R&D are slowly shifting these dynamics, enabling the introduction of next-generation vascular grafts with better clinical and commercial viability.

What Key Forces Are Accelerating Global Market Growth?

The growth in the artificial blood vessels market is driven by several factors that are deeply rooted in clinical needs, technological innovation, healthcare infrastructure expansion, and shifting treatment paradigms. Foremost among these is the increasing number of cardiovascular and peripheral vascular surgeries being performed worldwide, due in large part to the growing prevalence of lifestyle-induced chronic diseases and age-related vascular degeneration. Technological progress in biomaterials, such as the development of biodegradable polymers and bioactive coatings, has enabled the creation of artificial vessels that better resist infection, thrombosis, and mechanical fatigue. Rapid advancements in 3D printing, particularly bioprinting, are making it feasible to manufacture personalized grafts tailored to individual anatomy, thus reducing complications and improving surgical success rates. The expansion of dialysis care infrastructure is another major growth driver, given the high demand for vascular access solutions among patients undergoing chronic renal replacement therapy. Additionally, a growing number of specialized cardiovascular centers, especially in emerging markets, are incorporating artificial grafts into their standard surgical toolkits. Consumer behavior is also playing a role, with patients increasingly opting for early surgical intervention and minimally invasive approaches that require high-performance grafts. End-users, including hospitals, research institutions, and surgical centers, are increasingly favoring partnerships with medical device firms to co-develop next-gen graft technologies. Furthermore, the rise of telehealth and remote monitoring tools is enabling better post-operative management, improving outcomes and reinforcing confidence in artificial graft use. Collectively, these factors are propelling the global artificial blood vessels market toward a period of sustained innovation, rising adoption, and expansive growth.

SCOPE OF STUDY:

The report analyzes the Artificial Blood Vessels market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Polymer (Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer, Other Polymers); Application (Aortic Disease Application, Peripheral Artery Disease Application, Hemodialysis Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • ArtiCasc 3D
  • Artivion, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Getinge AB
  • Humacyte Inc.
  • Integra LifeSciences Holdings Corp.
  • Jiangsu Bioda Life Science Co., Ltd.
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Roumai Med
  • Smith & Nephew plc
  • Techshot Inc.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Blood Vessels - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Vascular Grafts in Cardiovascular Surgery Throws the Spotlight on Artificial Blood Vessels
    • Development of Biocompatible and Non-Thrombogenic Materials Improves Graft Longevity
    • Use in Coronary, Peripheral, and Dialysis-Related Procedures Sustains Diverse Clinical Demand
    • Advances in Electrospinning and Tissue Engineering Enable Scaffold-Free Vessel Fabrication
    • Focus on Small-Diameter Vessels Expands Possibilities in Coronary Applications
    • Increase in Endovascular and Minimally Invasive Techniques Spurs Compatibility Requirements
    • Integration With Drug-Eluting and Anti-Infection Coatings Enhances Post-Operative Outcomes
    • Expansion of Organ Transplant and Bypass Surgeries Drives Hospital Procurement
    • Longitudinal Studies Strengthen Evidence Base and Regulatory Confidence
    • Growing Interest in Personalized and 3D-Printed Vascular Grafts Supports Tailored Therapies
    • Use in Pediatric and Congenital Applications Highlights Unmet Needs in Niche Segments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Blood Vessels Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Polydioxanone Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Elastomer Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Polyethylene Terephthalate Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Polymers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Aortic Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Peripheral Artery Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hemodialysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • CHINA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • INDIA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030

IV. COMPETITION